missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human CDHR5 (aa 30-179) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (65%), Rat (65%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-82380 (PA5-82380. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
This gene is a novel mucin-like gene that is a member of the cadherin superfamily. While encoding nonpolymorphic tandem repeats rich in proline, serine and threonine similar to mucin proteins, the gene also contains sequence encoding calcium-binding motifs found in all cadherins. The role of the hybrid extracellular region and the specific function of this protein have not yet been determined. Alternatively spliced transcript variants encoding different isoforms have been described.
Specifications
Specifications
| Accession Number | Q9HBB8 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 53841 |
| Name | Human CDHR5 (aa 30-179) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | 1810074H01Rik; AI481143; Cadherin; cadherin related family member 5; cadherin-related family member 5; CDHR5; differentiation-associated catenin regulator; GP100; MLPCDH; MUCDHL; mucin and cadherin like; mucin and cadherin-like protein; Mucin-like protocadherin; Mupcdh; MU-PCDH; mu-protocadherin; UNQ2781/PRO7168 |
| Common Name | CDHR5 |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction